Abstract:Abstract 4-Androstene-3,17-dione (4-AD), 1,4-androstadiene-3,17-dione (ADD) and 9α-hydroxyl-4-androstene-3,17-dione (9OH-AD), which are important starting compounds for the synthesis of steroidal medicines, can be biosynthetically transformed from phytosterols by Mycobacterium strains. Genomic and metabolic analyses have revealed that currently available 4-AD-producing strains maintain the ability to convert 4-AD to ADD and 9OH-AD via 3-ketosteroid-1,2-dehydrogenase (KstD) and 3-ketosteroid-9α-hydroxylase (Ksh), not only lowering the production yield of 4-AD but also hampering its purification refinement. Additionally, these 4-AD industrial strains are excellent model strains to construct ADD- and 9OH-AD-producing strains. We recently found that Mycobacterium neoaurum HGMS2, a 4-AD-producing strain, harbored fewer kstd and ksh genes through whole-genomic and enzymatic analyses, compared with other strains (Wang et al. in Microbial Cell Fact 19:187, 2020). In this study, we attempted to construct an efficient 4-AD-producing strain by knocking out the kstd and ksh genes from the M. neoaurum HGMS2 strain. Next, we used kstd - and ksh -default HGMS2 mutants as templates to construct ADD- and 9OH-AD-producing strains by knocking in active kstd and ksh genes, respectively. We found that after knocking out its endogenous kstd and ksh genes, one of these knockout mutants, HGMS2 Δkstd211 + ΔkshB122 , showed a 20% increase in the rate of phytosterol to 4-AD conversion, compared relative to the wild-type strain and an increase in 4-AD yield to 38.3 g/L in pilot-scale fermentation. Furthermore, we obtained the ADD- and 9OH-AD-producing strains, HGMS2 kstd2 + Δkstd211+ΔkshB122 and HGMS2 kshA51 + Δkstd211+ΔkshA226 , by knocking in heterogenous active kstd and ksh genes to selected HGMS2 mutants, respectively. During pilot-scale fermentation, the conversion rates of the ADD- and 9OH-AD-producing mutants transforming phytosterol were 42.5 and 40.3%, respectively, and their yields reached 34.2 and 37.3 g/L, respectively. Overall, our study provides efficient strains for the production of 4-AD, ADD and 9OH-AD for the pharmaceutical industry and provides insights into the metabolic engineering of the HGMS2 strain to produce other important steroidal compounds.

Optimization of Biotransformation from Phytosterol to Androstenedione by A Mutant Mycobacterium Neoaurum Zjuvn-08

Optimization of bacteriocin production by a new Lactobacillus strain, ZJ317, using response surface methodology

Biotransformation optimization of betulin into betulinic acid production catalysed by cultured Armillaria luteo-virens Sacc ZJUQH100-6 cells.

Improving the biotransformation of phytosterols to 9α-hydroxy-4-androstene-3,17-dione by deleting embC associated with the assembly of cell envelope in Mycobacterium neoaurum

Enhancing Production and Purity of 9-OH-AD from Phytosterols by Balancing Metabolic Flux of the Side-Chain Degradation and 9-Position Hydroxylation in Mycobacterium Neoaurum

Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways

Metabolic Regulation of Androst-4-ene-3,17-dione 11Α-Hydroxylation Mutant Strain Metarhizium Anisopliae M28-203

Driving the Conversion of Phytosterol to 9Α-Hydroxy-4-androstene-3,17-dione in Mycolicibacterium Neoaurum by Engineering the Supply and Regeneration of Flavin Adenine Dinucleotide

Intracellular Environment Improvement of Mycobacterium neoaurum for Enhancing Androst-1,4-Diene-3,17-Dione Production by Manipulating NADH and Reactive Oxygen Species Levels

One-pot biosynthesis of 7β-hydroxyandrost-4-ene-3,17-dione from phytosterols by cofactor regeneration system in engineered mycolicibacterium neoaurum

Rerouting phytosterol degradation pathway for directed androst-1,4-diene-3,17-dione microbial bioconversion

Enhanced Steroid Metabolites Production By Resting Cell Phytosterol Bioconversion

Multidirectional pathway engineering of Mycobacterium Neoaurum LY-2 for the enhancement of androstenedione production from phytosterols

Process development of transforming phytosterols to steroidal pharmaceutical intermediates by Mycolicibacterium neoaurum with L-carnitine

A Combined Strategy to Enhance Phytosterols Biotransformation to 22-Hydroxy-23,24-bisnorchol-4-ene-3-one by Mycobacterium Neoaurum

Mutation Breeding of High 4-Androstene-3,17-dione-producing Mycobacterium Neoaurum ZADF-4 by Atmospheric and Room Temperature Plasma Treatment

Advances in Microbial Transformation of Phytosterols to Androstenedione

Driving the conversion of phytosterol to steroid synthons in Mycolicibacterium neoaurum by engineering the supply and regeneration of flavin adenine dinucleotide

Efficient conversion of phytosterols into 4-androstene-3,17-dione and its C1,2-dehydrogenized and 9α-hydroxylated derivatives by engineered Mycobacteria

Preparation, characterization, and biotransformation of the inclusion complex of phytosterols and hydroxypropyl-β-cyclodextrin by Mycobacterium neoaurum

Transformation Condition Optimization of 16Α-Hydroxylation of Prednisolone by Streptomyces Roseochromogenes